Multilayered molecular profiling supported the monoclonal origin of metastatic renal cell carcinomaYI HUANG; SHENGJIE GAO; ZIKE QIN et al.International journal of cancer (Print). 2014, Vol 135, Num 1, pp 78-87, issn 0020-7136, 10 p.Article

Laparoscopic renal cryoablation using ultrathin 17―gauge cryoprobes: mid―term oncological and functional resultsBEEMSTER, Patricia W. T; BARWARI, Kurdo; MAMOULAKIS, Charalampos et al.BJU international (Papier). 2011, Vol 108, Num 4, pp 577-582, issn 1464-4096, 6 p.Article

Family history of cancer and renal cell cancer risk in Caucasians and African AmericansKARAMI, S; SCHWARTZ, K; PURDUE, M. P et al.British journal of cancer. 2010, Vol 102, Num 11, pp 1676-1680, issn 0007-0920, 5 p.Article

Méningite et néoplasie rénale = Meningitis and renal cancerAMYAI, N; VAN LAETHEM, Y; BERGHMANS, T et al.Revue médicale de Bruxelles. 2009, Vol 30, Num 5, pp 507-510, issn 0035-3639, 4 p.Article

Prospective study of the relationship between the systemic inflammatory response, prognostic scoring systems and relapse-free and cancer-specific survival in patients undergoing potentially curative resection for renal cancerRAMSEY, Sara; LAMB, Gavin W. A; AITCHISON, Michael et al.BJU international (Papier). 2008, Vol 101, Num 8, pp 959-963, issn 1464-4096, 5 p.Article

The longitudinal relationship between the systemic inflammatory response, circulating T-lymphocytes, interleukin-6 and -10 in patients undergoing immunotherapy for metastatic renal cancerRAMSEY, Sara; AITCHISON, Michael; GRAHAM, John et al.BJU international (Papier). 2008, Vol 102, Num 1, pp 125-129, issn 1464-4096, 5 p.Article

Validation by Calibration of the UCLA Integrated Staging System Prognostic Model for Nonmetastatic Renal Cell Carcinoma After NephrectomyCINDOLO, Luca; CHIODINI, Paolo; GALLO, Ciro et al.Cancer. 2008, Vol 113, Num 1, pp 65-71, issn 0008-543X, 7 p.Article

Robotic nephrectomy for the treatment of benign and malignant diseaseROGERS, Craig; LAUNGANI, Rajesh; KRANE, Louis Spencer et al.BJU international (Papier). 2008, Vol 102, Num 11, pp 1660-1665, issn 1464-4096, 6 p.Article

The longitudinal relationship between circulating concentrations of C-reactive protein, interleukin-6 and interleukin-10 in patients undergoing resection for renal cancerRAMSEY, S; LAMB, G. W. A; AITCHISON, M et al.British journal of cancer. 2006, Vol 95, Num 8, pp 1076-1080, issn 0007-0920, 5 p.Article

Estimating the optimal external-beam radiotherapy utilization rate for genitourinary malignanciesDELANEY, Geoff; JACOB, Susannah; BARTON, Michael et al.Cancer. 2005, Vol 103, Num 3, pp 462-473, issn 0008-543X, 12 p.Article

Histologic predictors of renal cell carcinoma response to interleukin-2-based therapy. CommentaryUPTON, Melissa P; PARKER, Robert A; YOUMANS, Amanda et al.Journal of immunotherapy (1997). 2005, Vol 28, Num 5, pp 427-429, issn 1524-9557, 11 p.Article

Comparison of cryotherapy and nephrectomy in treating implanted VX-2 carcinoma in rabbit kidneysNAKADA, Stephen Y; JERDE, Travis J; WARNER, Thomas et al.BJU international (Papier). 2004, Vol 94, Num 4, pp 632-636, issn 1464-4096, 5 p.Article

Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patientsGUTWEIN, Paul; SCHRAMME, Anja; JUNG, Klaus et al.European journal of cancer (1990). 2009, Vol 45, Num 3, pp 478-489, issn 0959-8049, 12 p.Article

Brain metastasis in renal cancer patients: metastatic pattern, tumour-associated macrophages and chemokine/chemoreceptor expressionWYLER, L; NAPOLI, C. U; INGOLD, B et al.British journal of cancer. 2014, Vol 110, Num 3, pp 686-694, issn 0007-0920, 9 p.Article

Pretherapeutic gamma-glutamyltransferase is an independent prognostic factor for patients with renal cell carcinomaHOFBAUER, S. L; STANGL, K. I; DE MARTINO, M et al.British journal of cancer. 2014, Vol 111, Num 8, pp 1526-1531, issn 0007-0920, 6 p.Article

The association between physical activity and renal cancer: systematic review and meta-analysisBEHRENS, G; LEITZMANN, M. F.British journal of cancer. 2013, Vol 108, Num 4, pp 798-811, issn 0007-0920, 14 p.Article

miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosisMCCORMICK, R. I; BLICK, C; RAGOUSSIS, J et al.British journal of cancer. 2013, Vol 108, Num 5, pp 1133-1142, issn 0007-0920, 10 p.Article

Expression and prognostic significance of Src family members in renal clear cell carcinomaQAYYUM, T; MCARDLE, P. A; EDWARDS, J et al.British journal of cancer. 2012, Vol 107, Num 5, pp 856-863, issn 0007-0920, 8 p.Article

Renal cancer and pneumothorax risk in Birt―Hogg―Dubé syndrome; an analysis of II5 FLCN mutation carriers from 35 BHD familiesHOUWELING, A. C; GIJEZEN, L. M; DE JONG, M. M et al.British journal of cancer. 2011, Vol 105, Num 12, pp 1912-1919, issn 0007-0920, 8 p.Article

p53 and MDM2 in Renal Cell Carcinoma: Biomarkers for Disease Progression and Future Therapeutic Targets?NOON, Aidan P; VLATKOVIC, Nikolina; POLANSKI, Radosław et al.Cancer. 2010, Vol 116, Num 4, pp 780-790, issn 0008-543X, 11 p.Article

Inhibition of Proteasome Activity by Bortezomib in Renal Cancer Cells Is p53 Dependent and VHL IndependentVAZIRI, Susan A. J; GRABOWSKI, Dale R; HILL, Jason et al.Anticancer research. 2009, Vol 29, Num 8, pp 2961-2969, issn 0250-7005, 9 p.Article

Metastatic renal cancer and patient survival as a criterion of treatment responseSTATHOPOULOS, George P; KOUTANTOS, John; RIGATOS, Sotiris K et al.Oncology reports. 2008, Vol 19, Num 2, pp 477-481, issn 1021-335X, 5 p.Article

The relationship between the local and systemic inflammatory responses and survival in patients undergoing resection for localized renal cancerLAMB, Gavin W. A; MCARDLE, Peter A; RAMSEY, Sara et al.BJU international (Papier). 2008, Vol 102, Num 6, pp 756-761, issn 1464-4096, 6 p.Article

Topotecan and small interfering RNA suppress survivin expression synergistically in Caki-1 renal cancer cells : Direct suppression of survivin and enhancement of transfection efficiency by topotecanSATO, Akinori; ITO, Keiichi; ASANO, Takako et al.International journal of oncology. 2008, Vol 32, Num 1, pp 171-176, issn 1019-6439, 6 p.Article

Synergistic effect of survivin-specific small interfering RNA and topotecan in renal cancer cells : Topotecan enhances liposome-mediated transfection by increasing cellular uptakeSATO, Akinori; ITO, Keiichi; ASANO, Takako et al.International journal of oncology. 2007, Vol 30, Num 3, pp 695-700, issn 1019-6439, 6 p.Article